Ceregene's Series C Round

Ceregene raised a round of funding on February 14, 2007.

Ceregene is a San Diego-based biotechnology company focused on the development of nervous system growth factors (neurotrophic factors) as treatments for neurodegenerative and retinal disorders using g…

Articles about Ceregene's Series C Round: